Optimize Motor Learning to Improve Neurorehabilitation (OnLINE)

September 3, 2025 updated by: University of Bern
The objective of this study is to develop and evaluate novel robotic training strategies that modulate errors based on the subjects' individual motor and cognitive needs. For this purpose, healthy adults and neurologic patients will participate in robotic motor learning experiments. Patients have a diagnosis of a neurological disease (i.e., stroke, spinal cord injury, multiple sclerosis, Guillain-Barré syndrome) limiting arm motor function.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Neurological patients (e.g., after stroke) engage in intensive and expensive neurorehabilitation therapy to regain part of their former motor functional ability to perform everyday activities with often limited and unsatisfactory outcome. Robots became a promising supplement or even alternative for neurorehabilitation therapy, providing cost-effective, high repetition and task-oriented training. However, results of an initial body of work comparing the effectiveness of robotic training strategies are highly inconclusive. A possible explanation is that most current robotic systems cover only one neurorehabilitation strategy (e.g. reducing or augmenting movement errors) and may thus insufficiently address the subjects' individual needs and the characteristics of the task to be learned. In this study, Investigators will perform several motor learning experiments with healthy adult and neurological patients in order to evaluate the relative motor and cognitive benefits of newly developed robotic training strategies that modulate errors based on the subject's age, skill level and tasks characteristics. The effects of the new strategies will be compared to classical robotic assistance, and to non-robotic feedback approaches, such as visual feedback. The culmination of this work may help to optimize training benefits of already existing rehabilitation robots.

Study Type

Interventional

Enrollment (Actual)

259

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bern, Switzerland, 3010
        • University of Bern

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged ≥18 years
  • Informed Consent as documented by signature ("Informed Consent" form)
  • Bodyweight <120 kg
  • Ability to communicate effectively with the examiner so that the validity of the patient's data could not be compromised

Exclusion Criteria:

  • Excessive spasticity of the affected arm (Ashworth Scale ≥3)
  • Serious medical or psychiatric disorder
  • Orthopaedic, rheumatological, or other disease restricting movements of the paretic arm
  • Shoulder subluxation
  • Skin ulcerations at the paretic arm
  • Cyber-sickness (i.e., nausea when looking at a screen or playing computer games)
  • Serious cognitive defects or aphasia preventing effective use of the robotic devices
  • Severe visual and auditory impairments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robotic motor training
Participants will perform motor tasks (i.e. movements) with upper limb robotic devices applying different strategies (e.g. supporting or challenging the subject, or being fully compliant).
The experiments consist in performing motor tasks with upper-limb robotic devices.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in kinematic performance assessed by the robot
Time Frame: Baseline, training (immediately after baseline), retention (1-2 days after the training)
Motion changes from baseline in the kinematic variables assessed by the robot and motion trackers during the motor learning task. The kinematic performance analysis consists of end-effector position in the x, y, and z-axis, in meters, and joint angles in degrees.
Baseline, training (immediately after baseline), retention (1-2 days after the training)
Change in kinetic performance assessed by the robot
Time Frame: Baseline, training (immediately after baseline), retention (1-2 days after the training)
Force changes from baseline in the kinetic variables assessed by the robot using force sensors during the motor learning task. Kinetic performance analysis consists of interaction forces in x, y, and z-axis, in N and applied robot joint torques by the motors, in Nm.
Baseline, training (immediately after baseline), retention (1-2 days after the training)
Spatial analysis of changes in evoked potentials as assessed by Electroencephalography (EEG) measurement
Time Frame: Baseline, training (immediately after baseline), retention (1-2 days after the training)
Electroencephalographical assessment of changes in evoked potentials i.e. the electrical activity of the brain in response to stimulation of specific sensory nerve pathways.
Baseline, training (immediately after baseline), retention (1-2 days after the training)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in embodiment
Time Frame: Before Intervention, Immediately after the end of intervention
Virtual Reality (VR) Embodiment Scale, Self administered Likert scale of 1-7 (Strongly Disagree to Strongly Agree)
Before Intervention, Immediately after the end of intervention
Spatial analysis of changes in Task-Based Brain Connectivity as assessed by Electroencephalography (EEG) measurement
Time Frame: Baseline, training (immediately after baseline or 1-2 days after baseline), retention (1-2 days after the training)
Changes in Task-Based Brain Connectivity from baseline in electroencephalography measurement
Baseline, training (immediately after baseline or 1-2 days after baseline), retention (1-2 days after the training)
Change in Motivation as assessed by Intrinsic Motivation Inventory (IMI)
Time Frame: Before Intervention, Immediately after the end of intervention, at the end of the session
Intrinsic Motivation Inventory, Self administered. Likert scale of 1-7 (1: not at all true - 4: somewhat true - 7: very true)
Before Intervention, Immediately after the end of intervention, at the end of the session
Change in Cognitive Load as assessed by National Aeronautics and Space Administration (NASA) (Raw) Task Load Index
Time Frame: Immediately after the end of intervention, At the end of the session
Self-reported cognitive load during a task, Self-administered National Aeronautics and Space Administration (Raw) Task Load Index (TLX), analog scale mapped from 0 to 100 (Endpoints: Low/High, Good/Poor)
Immediately after the end of intervention, At the end of the session
System Usability as assessed by System Usability Scale (SUS)
Time Frame: Immediately after the end of intervention, At the end of the session
Self reported system usability assessed by System Usability Scale (SUS) Likert scale of 1-5 (Strongly agree to Strongly disagree)
Immediately after the end of intervention, At the end of the session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laura Marchal-Crespo, Prof. Dr., University of Bern, ARTORG Center for Biomedical Engineering Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 25, 2019

Primary Completion (Actual)

April 15, 2024

Study Completion (Actual)

October 16, 2024

Study Registration Dates

First Submitted

February 1, 2021

First Submitted That Met QC Criteria

February 15, 2021

First Posted (Actual)

February 18, 2021

Study Record Updates

Last Update Posted (Estimated)

September 4, 2025

Last Update Submitted That Met QC Criteria

September 3, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All individual participant data that underlie results in a publication

IPD Sharing Time Frame

Data will be available after publications and it will stay accessible as long as the journal regulation permits.

IPD Sharing Access Criteria

Being able to access the journal paper

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Robotic motor training

Subscribe